Biotoxtech Co., Ltd. (KOSDAQ:086040)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
R&D Services			32.63B	37.29B	32.72B	-	-
R&D Services Growth			-12.50%	13.98%	-	-	-
Total			32.63B	37.29B	32.72B	-	-
Total Growth			-12.50%	13.98%	-	-	-

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
South Korea			30.22B	36.04B	31.27B	24.88B	24.56B
South Korea Growth			-16.14%	15.27%	25.65%	1.33%	-1.77%
Overseas			2.41B	1.25B	1.45B	1.54B	1.30B
Overseas Growth			92.24%	-13.70%	-6.04%	19.13%	-42.27%
Total			32.63B	37.29B	32.72B	26.43B	25.85B
Total Growth			-12.50%	13.98%	23.80%	2.22%	-5.11%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 20, 2026

Data Sources Report a data error